Co-Diagnostics, Inc. (CODX)Healthcare | Medical Devices | Salt Lake City, United States | NasdaqCM
1.56 USD
+0.10
(6.849%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.57 +0.01 (0.333%) ⇧ (April 17, 2026, 7:27 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 11:42 p.m. EDT
Despite the company's aggressive M&A strategy and market expansion headlines showing a massive addressable market ($13B target), the fundamental reality is deteriorating: a massive -79% drop from 52-week highs to $1.56, negative operating cash flow, and the company's own 45-day forecasters predicting a nearly 28% further decline. The stock is trading at a bargain basement valuation ($1.19 realistically post-split) relative to book value, but the operational burn and earnings misses outweigh the potential. This is a high-risk 'lottery ticket' play driven solely on acquisition speculation, not organic growth. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.312465 |
| AutoETS | 0.318091 |
| AutoTheta | 0.458253 |
| AutoARIMA | 0.467142 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 11.54 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.416 |
| Excess Kurtosis | 0.93 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.994 |
| Revenue per Share | 0.468 |
| Market Cap | 5,619,845 |
| Forward P/E | -0.13 |
| Beta | 1.43 |
| Website | https://co-dx.com |
As of April 18, 2026, 11:42 p.m. EDT: Options flow indicates meaningful put concentration as a hedge/bottom-fishing mechanism, particularly at the $0.50 strike with high Open Interest (981) and at the $1.00 strike (1,100 OI). This $0.50-$1.00 zone acts as a major support floor where unwinding is happening. Call activity is muted outside of deep in-the-money positions, suggesting a lack of speculative upside momentum. The divergence between significant put OI at lower strikes and weak call volume above current price suggests speculators are positioning for further downside or protection against a continuation of the projected -28% move, rather than betting on a reversal.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8535211 |
| Address1 | 2,401 S. Foothill Dr. |
| Address2 | Suite D |
| All Time High | 929.7 |
| All Time Low | 1.35 |
| Ask | 1.6 |
| Ask Size | 1 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 122,810 |
| Average Daily Volume3 Month | 1,170,856 |
| Average Volume | 1,170,856 |
| Average Volume10Days | 122,810 |
| Beta | 1.428 |
| Bid | 1.52 |
| Bid Size | 1 |
| Board Risk | 10 |
| Book Value | 9.846 |
| City | Salt Lake City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.56 |
| Current Ratio | 3.869 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.6 |
| Day Low | 1.45 |
| Debt To Equity | 5.994 |
| Display Name | Co-Diagnostics |
| Earnings Call Timestamp End | 1,774,989,000 |
| Earnings Call Timestamp Start | 1,774,989,000 |
| Earnings Timestamp | 1,774,987,200 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -30,176,544 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.167 |
| Enterprise To Revenue | -8.078 |
| Enterprise Value | -5,028,202 |
| Eps Current Year | -12.15001 |
| Eps Forward | -12.00001 |
| Eps Trailing Twelve Months | -35.25 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.16288 |
| Fifty Day Average Change | -0.60288 |
| Fifty Day Average Change Percent | -0.27873945 |
| Fifty Two Week Change Percent | -85.35211 |
| Fifty Two Week High | 46.5 |
| Fifty Two Week High Change | -44.94 |
| Fifty Two Week High Change Percent | -0.9664516 |
| Fifty Two Week Low | 1.35 |
| Fifty Two Week Low Change | 0.20999992 |
| Fifty Two Week Low Change Percent | 0.15555549 |
| Fifty Two Week Range | 1.35 - 46.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,499,866,200,000 |
| Float Shares | 3,499,254 |
| Forward Eps | -12.00001 |
| Forward P E | -0.12999989 |
| Free Cashflow | -19,684,820 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 115 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.64276004 |
| Gross Profits | 400,112 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.040370002 |
| Implied Shares Outstanding | 3,602,465 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,026-03-11 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,767,312,000 |
| Last Split Factor | 1:30 |
| Long Business Summary | Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah. |
| Long Name | Co-Diagnostics, Inc. |
| Market | us_market |
| Market Cap | 5,619,845 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_60358987 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -46,895,936 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,619,845 |
| Open | 1.45 |
| Operating Cashflow | -29,136,928 |
| Operating Margins | -29.022911 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 801 438 1036 |
| Post Market Change | 0.0052000284 |
| Post Market Change Percent | 0.33333516 |
| Post Market Price | 1.5652 |
| Post Market Time | 1,776,468,433 |
| Previous Close | 1.46 |
| Price Eps Current Year | -0.12839495 |
| Price Hint | 4 |
| Price To Book | 0.15843998 |
| Price To Sales Trailing12 Months | 9.028023 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.424 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0999999 |
| Regular Market Change Percent | 6.84931 |
| Regular Market Day High | 1.6 |
| Regular Market Day Low | 1.45 |
| Regular Market Day Range | 1.45 - 1.6 |
| Regular Market Open | 1.45 |
| Regular Market Previous Close | 1.46 |
| Regular Market Price | 1.56 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 125,124 |
| Return On Assets | -0.44283 |
| Return On Equity | -1.25889 |
| Revenue Growth | 0.767 |
| Revenue Per Share | 0.468 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 3,602,465 |
| Shares Percent Shares Out | 0.0468 |
| Shares Short | 168,619 |
| Shares Short Previous Month Date | 1,767,139,200 |
| Shares Short Prior Month | 75,068 |
| Short Name | Co-Diagnostics, Inc. |
| Short Percent Of Float | 0.0484 |
| Short Ratio | 0.05 |
| Source Interval | 15 |
| State | UT |
| Symbol | CODX |
| Total Cash | 11,884,607 |
| Total Cash Per Share | 3.299 |
| Total Debt | 1,236,559 |
| Total Revenue | 622,489 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -35.25 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.38565 |
| Two Hundred Day Average Change | -5.82565 |
| Two Hundred Day Average Change Percent | -0.7887796 |
| Type Disp | Equity |
| Volume | 125,124 |
| Website | https://co-dx.com |
| Zip | 84,109 |